Front Row Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
Front Row Advisors's LH Position: Q3 2024 in Review
Front Row Advisors sold out of Labcorp (LH) in Q3 2024, closing a stake of 147 shares — an estimated $29.9K sold.
Front Row Advisors first reported a position in LH in Q4 2017 and held it in 26 quarters. The position peaked at $52K in Q4 2021. 920 funds tracked by Wall St. Rank hold LH as of Q3 2024.
- Front Row Advisors reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
- Front Row Advisors sold 147 Labcorp shares in Q3 2024, an estimated $29.9K.
- Front Row Advisors first reported a position in Labcorp in Q4 2017 and held it in 26 quarters.
- Front Row Advisors's Labcorp position peaked at $52K in Q4 2021.
- 920 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.
Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.